// App-Quantinova.ai

PB0502 : Prediction of bleeding risk in patients with cancer receiving anticoagulants

Researchers

Presenter

  • E. Trinks-Roerdink

Principal Investigators

  • S. van Doorn

Medical Centers

  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Utrecht, Utrecht, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Arrhythmia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved